research communications
H-pyridin-2-one): an active pharmaceutical ingredient (API)
of pirfenidone (5-methyl-1-phenyl-1aDipartimento di Scienze del Farmaco, Università del Piemonte Orientale, Largo Donegani 2/3, I-28100, Novara, Italy, bR&D Division, PROCOS S.p.A., Via G. Matteotti 249, 28062 Cameri (Novara), Italy, and cDipartimento di Chimica, Università degli Studi di Milano, Via Golgi 19, I-20133 Milano, Italy
*Correspondence e-mail: valentina.colombo@unimi.it
The 12H11NO [alternative name: 5-methyl-1-phenylpyridin-2(1H)-one], an active pharmaceutical ingredient (API) approved in Europe and Japan for the treatment of Idiopathic pulmonary fibrosis (IPF), is reported here for the first time. It was crystallized from toluene by the temperature gradient technique, and crystallizes in the chiral monoclinic P21. The phenyl and pyridone rings are inclined to each other by 50.30 (11)°. In the crystal, molecules are linked by C–H⋯O hydrogen bonds involving the same acceptor atom, forming undulating layers lying parallel to the ab plane.
of pirfenidone, CKeywords: crystal structure; pirfenidone; active pharmaceutical ingredient (API); idiopathic pulmonary fibrosis (IPF); hydrogen bonding.
CCDC reference: 1914224
1. Chemical context
Idiopathic Pulmonary Fibrosis (IPF) is a lung disease characterized by cough, scars and dyspnea that leads to progressive and irreversible loss of lung function. Pirfenidone (systematic name: 5-methyl-1-phenyl-1H-pyridin-2-one) has been approved in Japan since 2008 (Pirespa®) and in Europe since 2011 (Esbriet®) for the treatment of IPF, even if its mechanism of action has not been completely elucidated (Richeldi et al., 2011). Different synthetic approaches have been reported, mainly relying on N-arylation reactions of 5-methyl-2-pyridone (Liu et al., 2009; Crifar et al., 2014; Jung et al., 2016; Falb et al., 2017). Pirfenidone has been known since 1974 (Gadekar, 1974) and its antifibrotic properties were described in 1990 (Margolin, 1990). Nevertheless, despite its formulation as oral tablets, no information on the solid-state structure of this compound has been reported to date. In the present study, we report and analyse the of pirfenidone.
2. Structural commentary
The molecular structure of pirfenidone is shown in Fig. 1. This axially chiral molecule crystallizes in the monoclinic P21, with one molecule in a general position. The molecule is far from planar with the phenyl (C7–C12) and pyridinone (N1/C1–C5) rings subtending a dihedral angle of 50.30 (11)°.
3. Supramolecular features
In the crystal, molecules are linked by C—H⋯O hydrogen bonds involving the same acceptor atom (Table 1), forming an undulating network, enclosing R43(20) ring motifs, and lying parallel to the ab plane (Figs. 2 and 3). The R43(20) ring motifs are clearly visible in Fig. 3. There are no other significant intermolecular contacts present according to the analysis of the using PLATON (Spek, 2009).
4. Database Survey
A search of the Cambridge Structural Database (CSD, Version 5.40, February 2019; Groom et al., 2016) for 1-phenylpyridin-2(1H)-ones, excluding structures with ring atoms being included in further cyclic moieties, gave 40 hits (see supporting information file S1). Only six of these compounds involve an unsubstituted phenyl ring as in the title compound. When considering compounds with no substituent in position-6 of the pyridinone ring (on atom C5 in the title compound; Fig. 1) only three structures fit this extra criteria, viz. S-ethyl 2-oxo-1-phenyl-1,2-dihydro-3-pyridinecarbothioate (CSD refcode NOLBIA; Liu et al., 2008), monoclinic P21, 4-chloro-6-oxo-1-phenyl-1,6-dihydropyridine-3-carbaldehyde (QIWFIM; Xiang et al., 2008), monoclinic P21/c, and methyl 5-benzoyl-2-oxo-1-phenyl-1,2-dihydropyridine-4-carboxylate (TEMKIH; Shao et al., 2012), orthorhombic Pna21 with two independent molecules in the In these three compounds, the phenyl ring is inclined to the pyridone ring by ca 65.50, 64.66 and 55.83/57.12°, respectively. This dihedral angle in the title compound, pirfenidone, is 50.30 (11)°. In the other three compounds [AQIKIV (Gorobets et al., 2010), BAFPUV (Dyachenko et al., 2011) and WEDCEP (Allais et al., 2012) – see supporting information file S1] with a substituent in position-6 of the pyridinone ring the corresponding dihedral angle varies from ca 73.02 to 89.28° as a result of steric hindrance.
5. Synthesis and crystallization
Pirfenidone was obtained in > 99.5% purity according to the method published previously (Mossotti et al., 2018). Single crystals were grown in the following way: approximately 100 mg of pirfenidone in 2 mL of toluene was heated until complete dissolution. The flask with this solution was then closed and kept at 273–278 K. Well-formed colourless crystals of pirfenidone were obtained after 1 week. The melting point of this crystal form, determined by DSC analysis (heating rate 10 K min−1), is 383 K. This crystallization procedure must be performed in order to grow single crystals suitable for X-ray and not with the aim of increasing the purity of the product. It is worth nothing that the industrial process is already optimized for the isolation of a pure API (> 99.5%) and a further crystallization step is not needed to improve its purity. We performed several other crystallization trials in order to search for other possible forms of pirfenidone; however, each crystallization attempt gave rise to the same crystal form.
6. Refinement
Crystal data, data collection and structure . The H atoms were included in calculated positions and treated as riding: C—H = 0.93–0.96 Å with Uiso(H) = 1.5Ueq(C-methyl) and 1.2Ueq(C) for other H atoms.
details are summarized in Table 2Supporting information
CCDC reference: 1914224
https://doi.org/10.1107/S2056989019006418/tx2011sup1.cif
contains datablocks Pirfenidone, Global. DOI:CSD search results. DOI: https://doi.org/10.1107/S2056989019006418/tx2011sup3.pdf
Data collection: APEX2 (Bruker, 2010); cell
SAINT (Bruker, 2010); data reduction: SAINT (Bruker, 2010); program(s) used to solve structure: SHELXT2017 (Sheldrick, 2015a); program(s) used to refine structure: SHELXL2017 (Sheldrick, 2015b); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012) and Mercury (Macrae et al., 2008); software used to prepare material for publication: SHELXL2017 (Sheldrick, 2015b), PLATON (Spek, 2009) and publCIF (Westrip, 2010).C12H11NO | Dx = 1.269 Mg m−3 |
Mr = 185.22 | Melting point: 375 K |
Monoclinic, P21 | Mo Kα radiation, λ = 0.71073 Å |
a = 6.2525 (8) Å | Cell parameters from 2547 reflections |
b = 7.797 (1) Å | θ = 3.3–27.2° |
c = 10.2810 (13) Å | µ = 0.08 mm−1 |
β = 104.744 (2)° | T = 293 K |
V = 484.70 (11) Å3 | Plate, colourless |
Z = 2 | 0.50 × 0.45 × 0.05 mm |
F(000) = 196 |
Bruker SMART APEX CCD diffractometer | 1879 reflections with I > 2σ(I) |
ω scans | Rint = 0.019 |
Absorption correction: multi-scan (SADABS; Bruker, 2010) | θmax = 27.2°, θmin = 2.1° |
Tmin = 0.692, Tmax = 0.746 | h = −8→8 |
4547 measured reflections | k = −9→10 |
2128 independent reflections | l = −13→13 |
Refinement on F2 | Hydrogen site location: inferred from neighbouring sites |
Least-squares matrix: full | H-atom parameters constrained |
R[F2 > 2σ(F2)] = 0.037 | w = 1/[σ2(Fo2) + (0.0528P)2 + 0.0476P] where P = (Fo2 + 2Fc2)/3 |
wR(F2) = 0.095 | (Δ/σ)max < 0.001 |
S = 1.04 | Δρmax = 0.11 e Å−3 |
2128 reflections | Δρmin = −0.20 e Å−3 |
127 parameters | Absolute structure: Flack x determined using 762 quotients [(I+)-(I-)]/[(I+)+(I-)] (Parsons et al., 2013) |
1 restraint | Absolute structure parameter: 0.3 (4) |
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. |
Refinement. none |
x | y | z | Uiso*/Ueq | ||
N1 | 0.7599 (2) | 0.5275 (2) | 0.62509 (16) | 0.0382 (4) | |
O1 | 1.0951 (2) | 0.6634 (3) | 0.69330 (17) | 0.0602 (5) | |
C1 | 0.9386 (3) | 0.6188 (3) | 0.6002 (2) | 0.0437 (5) | |
C5 | 0.5769 (3) | 0.4849 (3) | 0.5233 (2) | 0.0395 (5) | |
H5 | 0.460421 | 0.428046 | 0.545647 | 0.047* | |
C7 | 0.7635 (3) | 0.4782 (3) | 0.76141 (19) | 0.0401 (5) | |
C4 | 0.5595 (3) | 0.5219 (3) | 0.3929 (2) | 0.0430 (5) | |
C12 | 0.9445 (4) | 0.3913 (3) | 0.8390 (2) | 0.0497 (5) | |
H12 | 1.066616 | 0.368712 | 0.805687 | 0.060* | |
C8 | 0.5830 (3) | 0.5134 (3) | 0.8108 (2) | 0.0481 (5) | |
H8 | 0.462114 | 0.572084 | 0.758231 | 0.058* | |
C6 | 0.3599 (4) | 0.4732 (3) | 0.2835 (2) | 0.0579 (6) | |
H6A | 0.400128 | 0.387266 | 0.227127 | 0.087* | |
H6B | 0.304346 | 0.572565 | 0.230447 | 0.087* | |
H6C | 0.247695 | 0.428652 | 0.322817 | 0.087* | |
C11 | 0.9409 (5) | 0.3383 (3) | 0.9672 (2) | 0.0616 (7) | |
H11 | 1.061057 | 0.278817 | 1.019737 | 0.074* | |
C3 | 0.7416 (4) | 0.6079 (3) | 0.3637 (2) | 0.0527 (6) | |
H3 | 0.737708 | 0.633055 | 0.274701 | 0.063* | |
C2 | 0.9189 (4) | 0.6537 (3) | 0.4608 (2) | 0.0540 (6) | |
H2 | 1.033979 | 0.710617 | 0.436893 | 0.065* | |
C9 | 0.5836 (4) | 0.4604 (4) | 0.9395 (2) | 0.0623 (7) | |
H9 | 0.462501 | 0.484254 | 0.973553 | 0.075* | |
C10 | 0.7616 (5) | 0.3728 (4) | 1.0174 (2) | 0.0649 (7) | |
H10 | 0.760634 | 0.337171 | 1.103577 | 0.078* |
U11 | U22 | U33 | U12 | U13 | U23 | |
N1 | 0.0355 (8) | 0.0426 (9) | 0.0362 (8) | 0.0009 (8) | 0.0084 (7) | 0.0007 (7) |
O1 | 0.0399 (8) | 0.0725 (11) | 0.0631 (11) | −0.0111 (8) | 0.0038 (7) | −0.0046 (9) |
C1 | 0.0368 (10) | 0.0430 (12) | 0.0524 (12) | 0.0007 (9) | 0.0134 (9) | −0.0023 (10) |
C5 | 0.0380 (9) | 0.0395 (11) | 0.0398 (10) | −0.0026 (9) | 0.0078 (8) | 0.0011 (9) |
C7 | 0.0411 (10) | 0.0397 (11) | 0.0362 (10) | −0.0013 (8) | 0.0034 (8) | 0.0002 (8) |
C4 | 0.0524 (11) | 0.0376 (11) | 0.0376 (10) | −0.0009 (10) | 0.0087 (9) | −0.0001 (9) |
C12 | 0.0496 (12) | 0.0478 (12) | 0.0459 (12) | 0.0081 (10) | 0.0017 (10) | −0.0051 (10) |
C8 | 0.0395 (10) | 0.0602 (13) | 0.0435 (11) | −0.0003 (10) | 0.0082 (8) | 0.0070 (11) |
C6 | 0.0705 (15) | 0.0570 (15) | 0.0399 (11) | −0.0077 (13) | 0.0026 (11) | −0.0004 (11) |
C11 | 0.0708 (16) | 0.0522 (14) | 0.0469 (13) | 0.0053 (12) | −0.0126 (12) | 0.0046 (11) |
C3 | 0.0694 (15) | 0.0522 (14) | 0.0410 (11) | −0.0091 (11) | 0.0224 (11) | 0.0002 (10) |
C2 | 0.0559 (13) | 0.0556 (14) | 0.0576 (14) | −0.0113 (12) | 0.0276 (11) | −0.0015 (11) |
C9 | 0.0595 (14) | 0.0851 (19) | 0.0450 (13) | −0.0110 (13) | 0.0183 (11) | 0.0036 (13) |
C10 | 0.0826 (19) | 0.0688 (17) | 0.0378 (12) | −0.0134 (16) | 0.0054 (12) | 0.0103 (12) |
N1—C5 | 1.381 (2) | C8—C9 | 1.386 (3) |
N1—C1 | 1.402 (2) | C8—H8 | 0.9300 |
N1—C7 | 1.448 (3) | C6—H6A | 0.9600 |
O1—C1 | 1.232 (3) | C6—H6B | 0.9600 |
C1—C2 | 1.432 (3) | C6—H6C | 0.9600 |
C5—C4 | 1.349 (3) | C11—C10 | 1.375 (4) |
C5—H5 | 0.9300 | C11—H11 | 0.9300 |
C7—C8 | 1.378 (3) | C3—C2 | 1.338 (3) |
C7—C12 | 1.384 (3) | C3—H3 | 0.9300 |
C4—C3 | 1.417 (3) | C2—H2 | 0.9300 |
C4—C6 | 1.501 (3) | C9—C10 | 1.376 (4) |
C12—C11 | 1.386 (4) | C9—H9 | 0.9300 |
C12—H12 | 0.9300 | C10—H10 | 0.9300 |
C5—N1—C1 | 121.93 (17) | C4—C6—H6A | 109.5 |
C5—N1—C7 | 118.39 (16) | C4—C6—H6B | 109.5 |
C1—N1—C7 | 119.67 (16) | H6A—C6—H6B | 109.5 |
O1—C1—N1 | 120.88 (19) | C4—C6—H6C | 109.5 |
O1—C1—C2 | 124.9 (2) | H6A—C6—H6C | 109.5 |
N1—C1—C2 | 114.20 (18) | H6B—C6—H6C | 109.5 |
C4—C5—N1 | 122.94 (19) | C10—C11—C12 | 120.7 (2) |
C4—C5—H5 | 118.5 | C10—C11—H11 | 119.7 |
N1—C5—H5 | 118.5 | C12—C11—H11 | 119.7 |
C8—C7—C12 | 120.74 (19) | C2—C3—C4 | 121.7 (2) |
C8—C7—N1 | 119.42 (17) | C2—C3—H3 | 119.1 |
C12—C7—N1 | 119.81 (19) | C4—C3—H3 | 119.1 |
C5—C4—C3 | 116.47 (19) | C3—C2—C1 | 122.6 (2) |
C5—C4—C6 | 122.2 (2) | C3—C2—H2 | 118.7 |
C3—C4—C6 | 121.4 (2) | C1—C2—H2 | 118.7 |
C7—C12—C11 | 119.0 (2) | C10—C9—C8 | 120.6 (2) |
C7—C12—H12 | 120.5 | C10—C9—H9 | 119.7 |
C11—C12—H12 | 120.5 | C8—C9—H9 | 119.7 |
C7—C8—C9 | 119.3 (2) | C11—C10—C9 | 119.7 (2) |
C7—C8—H8 | 120.4 | C11—C10—H10 | 120.2 |
C9—C8—H8 | 120.4 | C9—C10—H10 | 120.2 |
D—H···A | D—H | H···A | D···A | D—H···A |
C8—H8···O1i | 0.93 | 2.33 | 3.203 (3) | 156 |
C10—H10···O1ii | 0.93 | 2.46 | 3.310 (3) | 152 |
Symmetry codes: (i) x−1, y, z; (ii) −x+2, y−1/2, −z+2. |
Acknowledgements
VC gratefully acknowledges Professor H. Stoeckli-Evans for her helpful and valuable suggestions.
Funding information
Funding for this research was provided by: Università degli Studi di Milano (grant No. PSR2018_DIP_005_COLOMBO_VALENTINA to Valentina Colombo).
References
Allais, C., Baslé, O., Grassot, J.-M., Fontaine, M., Anguille, S., Rodriguez, J. & Constantieux, T. (2012). Adv. Synth. Catal. 354, 2084–2088. Web of Science CSD CrossRef CAS Google Scholar
Bruker (2010). APEX2, SAINT, and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA. Google Scholar
Crifar, C., Petiot, P., Ahmad, T. & Gagnon, A. (2014). Chem. Eur. J. 20, 2755–2760. Web of Science CrossRef CAS PubMed Google Scholar
Dyachenko, V. D., Butyukova, O. S., Dyachenko, A. D. & Shishkin, O. V. (2011). Zh. Obshch. Khim. 81, 857–868. Google Scholar
Falb, E., Ulanenko, K., Tor, A., Gottesfeld, R., Weitman, M., Afri, M., Gottlieb, H. & Hassner, A. (2017). Green Chem. 19, 5046–5053. Web of Science CrossRef CAS Google Scholar
Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849–854. Web of Science CrossRef CAS IUCr Journals Google Scholar
Gadekar, S. M. (1974). Patent DE 2362958. Google Scholar
Groom, C. R., Bruno, I. J., Lightfoot, M. P. & Ward, S. C. (2016). Acta Cryst. B72, 171–179. Web of Science CrossRef IUCr Journals Google Scholar
Jung, S.-H., Sung, D.-B., Park, C.-H. & Kim, W.-S. (2016). J. Org. Chem. 81, 7717–7724. Web of Science CrossRef CAS PubMed Google Scholar
Liu, J., Liang, D., Wang, M. & Liu, Q. (2008). Synthesis, pp. 3633–3638. Web of Science CSD CrossRef Google Scholar
Liu, K. K.-C., Sakya, S. M., O'Donnell, C. J. & Li, J. (2009). Mini Rev. Med. Chem. 9, 1655–1675. Web of Science CrossRef CAS PubMed Google Scholar
Macrae, C. F., Bruno, I. J., Chisholm, J. A., Edgington, P. R., McCabe, P., Pidcock, E., Rodriguez-Monge, L., Taylor, R., van de Streek, J. & Wood, P. A. (2008). J. Appl. Cryst. 41, 466–470. Web of Science CrossRef CAS IUCr Journals Google Scholar
Margolin, S. B. C. O. T. (1990). Patent EP 0383591. Google Scholar
Mossotti, M., Barozza, A., Roletto, J. & Paissoni, P. (2018). Patent US 2018319747. Google Scholar
Parsons, S., Flack, H. D. & Wagner, T. (2013). Acta Cryst. B69, 249–259. Web of Science CrossRef CAS IUCr Journals Google Scholar
Richeldi, L., Yasothan, U. & Kirkpatrick, P. (2011). Nat. Rev. Drug Discov. 10, 489–490. Web of Science CrossRef CAS PubMed Google Scholar
Shao, Y., Yao, W., Liu, J., Zhu, K. & Li, Y. (2012). Synthesis, 44, 3301–3306. Web of Science CrossRef CAS Google Scholar
Sheldrick, G. M. (2015a). Acta Cryst. A71, 3–8. Web of Science CrossRef IUCr Journals Google Scholar
Sheldrick, G. M. (2015b). Acta Cryst. C71, 3–8. Web of Science CrossRef IUCr Journals Google Scholar
Spek, A. L. (2009). Acta Cryst. D65, 148–155. Web of Science CrossRef CAS IUCr Journals Google Scholar
Gorobets, N. Yu., Tkachova, V. P., Tkachov, R. P., Dyachenko, O. D., Rusanov, E. B. & Dyachenko, V. D. (2010). ARKIVOC, 11, 254–264. Google Scholar
Westrip, S. P. (2010). J. Appl. Cryst. 43, 920–925. Web of Science CrossRef CAS IUCr Journals Google Scholar
Xiang, D., Wang, K., Liang, Y., Zhou, G. & Dong, D. (2008). Org. Lett. 10, 345–348. Web of Science CSD CrossRef PubMed CAS Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.